MA42618A - Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés - Google Patents
Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylésInfo
- Publication number
- MA42618A MA42618A MA042618A MA42618A MA42618A MA 42618 A MA42618 A MA 42618A MA 042618 A MA042618 A MA 042618A MA 42618 A MA42618 A MA 42618A MA 42618 A MA42618 A MA 42618A
- Authority
- MA
- Morocco
- Prior art keywords
- fatty acids
- cétyl
- preparation
- system used
- cetyl
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title 2
- 229930195729 fatty acid Natural products 0.000 title 2
- 239000000194 fatty acid Substances 0.000 title 2
- -1 CETYL FATTY ACIDS Chemical class 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/003—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/08—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with fatty acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2015A003130A ITUB20153130A1 (it) | 2015-08-14 | 2015-08-14 | Acidi grassi cetilati, impianto per la loro preparazione e relativo uso |
| PCT/IB2016/054788 WO2017029580A1 (fr) | 2015-08-14 | 2016-08-09 | Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA42618A true MA42618A (fr) | 2021-04-07 |
| MA42618B1 MA42618B1 (fr) | 2021-10-29 |
Family
ID=55069943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA42618A MA42618B1 (fr) | 2015-08-14 | 2016-08-09 | Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10597608B2 (fr) |
| EP (2) | EP3943478A1 (fr) |
| CN (1) | CN108137472B (fr) |
| CA (1) | CA2995314C (fr) |
| CY (1) | CY1124710T1 (fr) |
| DK (1) | DK3334705T3 (fr) |
| ES (1) | ES2897903T3 (fr) |
| HR (1) | HRP20211702T1 (fr) |
| HU (1) | HUE056361T2 (fr) |
| IL (2) | IL257143B (fr) |
| IT (1) | ITUB20153130A1 (fr) |
| LT (1) | LT3334705T (fr) |
| MA (1) | MA42618B1 (fr) |
| MD (1) | MD3334705T2 (fr) |
| MY (1) | MY182324A (fr) |
| PL (1) | PL3334705T3 (fr) |
| PT (1) | PT3334705T (fr) |
| RS (1) | RS62429B1 (fr) |
| RU (1) | RU2756515C2 (fr) |
| SI (1) | SI3334705T1 (fr) |
| SM (1) | SMT202100697T1 (fr) |
| WO (1) | WO2017029580A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700089258A1 (it) | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
| IT201900007326A1 (it) * | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari |
| IT201900007311A1 (it) * | 2019-05-27 | 2020-11-27 | Alesco Srl | Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati |
| IT201900007329A1 (it) * | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia |
| IT202100030170A1 (it) | 2021-11-29 | 2023-05-29 | Pharmanutra S P A | Cerotto transdermico, e uso di detto cerotto in un metodo di trattamento di un disturbo, o disordine, o patologia, di un tendine |
| IT202300004227A1 (it) | 2023-03-07 | 2024-09-07 | Pharmanutra S P A | Composizioni comprendenti acidi grassi cetilati e vitamina d, e loro usi relativi |
| CN116693390A (zh) * | 2023-06-28 | 2023-09-05 | 广东聚石科技研究院有限公司 | 一种鲸蜡硬脂醇与脂肪酸的组合物及其制备方法与应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4049824A (en) * | 1976-05-03 | 1977-09-20 | Harry Weldon Diehl | Cetyl myristoleate |
| DE3468433D1 (en) * | 1983-05-19 | 1988-02-11 | Asahi Denka Kogyo Kk | Reaction method for transesterifying fats and oils |
| GB2233227A (en) * | 1989-06-09 | 1991-01-09 | Paul Eldred Buckenham | Zinc compositions for treatment of foot odour |
| CN1197688A (zh) * | 1997-04-29 | 1998-11-04 | 德国泰克萨科股份公司 | 在反应塔中物质的化学反应方法 |
| US5898077A (en) * | 1997-10-07 | 1999-04-27 | Matsumoto Yushi-Seiyaku Co., Ltd. | Process for preparation of an ester |
| WO2001085162A1 (fr) * | 2000-05-12 | 2001-11-15 | Meracol Corporation Limited | Traitement du syndrome ou de la maladie du colon irritable |
| NZ522434A (en) * | 2001-05-11 | 2005-09-30 | Meracol Corp Ltd | Treating eczema and/or psoriasis |
| CA2459087C (fr) * | 2001-08-31 | 2011-04-19 | Dianne Cadwallader | Synthese de fragments alkyle a chaine longue a liaison ester |
| DE10251984A1 (de) * | 2002-11-08 | 2004-05-19 | Cognis Deutschland Gmbh & Co. Kg | Verfahren zur Herstellung eines Esters |
| TWI324592B (en) * | 2002-11-28 | 2010-05-11 | Sulzer Chemtech Ag | A method for the esterification of a fatty acid |
| WO2004084829A2 (fr) * | 2003-03-20 | 2004-10-07 | Imagenetix, Inc. | Composition d'acide gras esterifie |
| RU2228745C1 (ru) * | 2003-04-16 | 2004-05-20 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Адаптогенный лекарственный перепарат для перорального применения |
| US8815282B1 (en) * | 2005-07-15 | 2014-08-26 | Edward C. Leonard | Commercial method for production of room temperature-liquid cetyl myristoleate |
| US7276621B2 (en) * | 2005-08-12 | 2007-10-02 | Eastman Chemical Company | Production of di-(2-ethylhexyl) terephthalate |
| BRPI0818795A8 (pt) * | 2007-10-30 | 2016-04-26 | Bayer Technology Services Gmbh | Processo para a esterificação heterogenicamente catalisada de ácidos graxos |
| US8394759B2 (en) * | 2008-11-21 | 2013-03-12 | Cymbiotics, Inc. | Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes |
| US20110039928A1 (en) * | 2009-08-13 | 2011-02-17 | Golini Jeffrey M | Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition |
| US20110135627A1 (en) * | 2009-10-07 | 2011-06-09 | The Inflasoothe Group, Inc. | Pain relief composition, system and method |
| EP2543364A1 (fr) * | 2010-10-14 | 2013-01-09 | Deva Holding Anonim Sirketi | Formulations de cetyl myristate et/ou cetyl palmitate |
| CN103880656A (zh) * | 2012-12-24 | 2014-06-25 | 青岛帅王油脂化学有限公司 | 一种脂肪酸酯化的方法 |
-
2015
- 2015-08-14 IT ITUB2015A003130A patent/ITUB20153130A1/it unknown
-
2016
- 2016-08-09 ES ES16767360T patent/ES2897903T3/es active Active
- 2016-08-09 RU RU2018108294A patent/RU2756515C2/ru active
- 2016-08-09 MD MDE20180613T patent/MD3334705T2/ro unknown
- 2016-08-09 MA MA42618A patent/MA42618B1/fr unknown
- 2016-08-09 LT LTEPPCT/IB2016/054788T patent/LT3334705T/lt unknown
- 2016-08-09 EP EP21189422.5A patent/EP3943478A1/fr active Pending
- 2016-08-09 IL IL257143A patent/IL257143B/en unknown
- 2016-08-09 CN CN201680047292.1A patent/CN108137472B/zh active Active
- 2016-08-09 RS RS20211241A patent/RS62429B1/sr unknown
- 2016-08-09 IL IL294422A patent/IL294422B2/en unknown
- 2016-08-09 DK DK16767360.7T patent/DK3334705T3/da active
- 2016-08-09 SI SI201631348T patent/SI3334705T1/sl unknown
- 2016-08-09 SM SM20210697T patent/SMT202100697T1/it unknown
- 2016-08-09 HR HRP20211702TT patent/HRP20211702T1/hr unknown
- 2016-08-09 HU HUE16767360A patent/HUE056361T2/hu unknown
- 2016-08-09 PL PL16767360T patent/PL3334705T3/pl unknown
- 2016-08-09 US US15/750,485 patent/US10597608B2/en active Active
- 2016-08-09 MY MYPI2018700478A patent/MY182324A/en unknown
- 2016-08-09 PT PT167673607T patent/PT3334705T/pt unknown
- 2016-08-09 EP EP16767360.7A patent/EP3334705B1/fr active Active
- 2016-08-09 WO PCT/IB2016/054788 patent/WO2017029580A1/fr not_active Ceased
- 2016-08-09 CA CA2995314A patent/CA2995314C/fr active Active
-
2020
- 2020-02-12 US US16/789,289 patent/US11186536B2/en active Active
-
2021
- 2021-11-09 CY CY20211100973T patent/CY1124710T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA42618A (fr) | Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés | |
| EP3448386A4 (fr) | Isoquinolin-3-yl carboxamides et préparation et utilisation de ceux-ci | |
| EP3394825A4 (fr) | Plateforme et système de médecine personnalisée numérique | |
| EP3448838A4 (fr) | Isoquinolin-3-yl carboxamides et préparation et utilisation de ceux-ci | |
| IL261805A (en) | Method and apparatus for delivery of therapeutic agents | |
| EP3265113A4 (fr) | Anticorps anti-lilrb et leur utilisation pour détecter et traiter un cancer | |
| IL259571A (en) | Cannabis oil compositions and methods for preparation thereof | |
| IL289099A (en) | Methods for the storage of whole blood, and compositions thereof | |
| EP3364969A4 (fr) | Méthodes de préparation de lymphocytes t pour traitement par lymphocytes t | |
| EP3436902A4 (fr) | Système d'interface homme-ordinateur | |
| MA50482A (fr) | Dérivés cyclisés de sulfamoylarylamide et leur utilisation comme médicaments pour le traitement de l'hépatite b | |
| MA45613A (fr) | Composés polycycliques-carbamoylpyridones et leur utilisation pharmaceutique | |
| EP3385262A4 (fr) | Inhibiteur de protéine kinase, son procédé de préparation et son utilisation médicale | |
| EP2914256A4 (fr) | Acides aminés disubstitués et procédés de préparation et d'utilisation de ceux-ci | |
| IL252418B (en) | Envenomation therapies and related pharmaceutical compositions, systems and kits | |
| EP3295988A4 (fr) | Microsonde endoscopique oct, système d'imagerie oct, et son procédé d'utilisation | |
| DK3474931T3 (da) | Botulinumtoksin-forfyldt sprøjtesystem | |
| EP3381451A4 (fr) | Composition pharmaceutique utilisée pour réduire la graisse localisée et utilisation de la composition pharmaceutique | |
| IL257371A (en) | Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient | |
| EP3131465A4 (fr) | Système et procédé pour une émission améliorée de la lumière vers et depuis des sujets | |
| EP3435788A4 (fr) | Comprimés bicouches de vitamines et leur procédé de préparation | |
| FR3032353B1 (fr) | Composition pharmaceutique et dispositif pour le traitement de la douleur | |
| EP3145562A4 (fr) | Appareil et procédé pour la préparation et l'administration de composants sanguins | |
| EP3395329A4 (fr) | Procédé de préparation de corps lipidiques et leur utilisation | |
| EP3344613A4 (fr) | Composés hétéroaryle et leur utilisation comme médicaments thérapeutiques |